Only way to enrich themselves is to get the stock price up over their stock option 3xercise price. Do you know what that price is for Amit and Kevin? You might want to start there with your DD.
What is the 'Altman Z-Score'
The Altman Z-score is the output of a credit-strength test that gauges a publicly traded manufacturing company's likelihood of bankruptcy. The Altman Z-score is based on five financial ratios that can be calculated from data found on a company's annual 10K report. It uses profitability, leverage, liquidity, solvency and activity to predict whether a company has a high degree of probability of being insolvent.
Busted like I said below, not for Biotechnology move on.
It is a non issue. We were granted the patents, we own the technology for while.
And the 40 million a year in top line revenue helps a little as well.
I don't think that will change any plans, sales are revenue and that is the primary goal for all for profit organizations.
Nope, the patent was granted giving them patent protection. They will prove the patent and we will find out who is playing games soon enough.
Eisai passed what over? Are you insane? We will never partner anything else with Eisai, Amit even said that a while back. They are a horrible marketing partner. They do not have a clue about what it takes to build a billion dollar blockbuster. They failed with Aricept as well and had to bring on Pfizer to help them sell that drug.
Short interest is staying fairly flat the last few reports. Not sure if they can't cover or if they are choosing to stay long, betting on dilution or abother takedown before the eventual run up into catalyst.
That would require you to be unbiased and to have looked at a lot more stocks that Arena because there is a lot of garbage out there.
Smoking off the table, Eisai did a market feasibility study and decided that they were not going move forward. I do not agree with their findings or their reasoning, they are gun shy after seeing Aricept go generic.
Enough with the personal attacks. This is a stock board, a place to debate the merits of ARNA as an investment. GROW UP
Played with the new interface. HATE IT...
Just makes it even that much harder to have a debate or share thoughts and ideas... Nothing more than an opinion/comment board now. Not very intuitive and not very organized....
are they going to general comment style message boards? Conversations looks a lot like a comment section.
It was just there and as we move to the end of the year it will move even higher going into weight loss season driven by the catalyst of Belviq XR, new weight loss season, results from the Phase 2 staring to reflect in the price from anticipation..